Assembly Biosciences, Inc. (ASMB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -22.1M | 14.24M | -15.13M | -16.76M | -23.44M | -407K | -15.24M | -17.1M | -18.36M | 73.65M | -13.85M | -13.63M |
| Operating CF Margin % | -269.05% | 33.52% | -140.26% | -174.09% | -248.85% | -5.53% | -222.7% | -200.42% | -317.44% | 1028.16% | - | - |
| Operating CF Growth % | 5.73% | 3598.03% | 0.73% | 2.01% | -27.64% | -100.55% | -10.08% | -25.49% | 21.62% | 482.5% | 30.14% | 23.8% |
| Net Income | -9.08M | 22.09M | -9.2M | -10.2M | -8.82M | -10.34M | -9.61M | -11.15M | -9.08M | -10.96M | -14.42M | -16.9M |
| Depreciation & Amortization | 0 | 32K | 32K | 32K | 33K | 32K | 33K | 32K | 32K | 84K | 116K | 126K |
| Stock-Based Compensation | 0 | 1.46M | 1.67M | 834K | 712K | 751K | 797K | 833K | 739K | 959K | 1.14M | 1.19M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 557K | -627K | -422K | -160K | -289K | -240K | -490K | -606K | -905K | 70K | 503K | 685K |
| Working Capital Changes | -13.57M | -8.72M | -7.22M | -7.27M | -15.08M | 9.38M | -5.97M | -6.21M | -9.15M | 83.5M | -1.18M | 1.27M |
| Change in Receivables | 523K | -62K | -912K | 0 | 0 | 0 | 0 | 43K | 0 | -43K | 342K | 375K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -42K | -512K | 940K | -132K | 290K | -750K | 534K | 74K | 266K | -297K | -146K | -320K |
| Cash from Investing | -5.38M | 21.22M | -158.27M | 16.99M | 6.59M | -6.7M | 24.49M | 5.11M | 17.27M | -89.65M | 18.88M | -8.37M |
| Capital Expenditures | -19K | -24K | -42K | 0 | 0 | 0 | 0 | -14K | -14K | -71K | -136K | -48K |
| CapEx % of Revenue | 0.23% | 0.06% | 0.39% | - | - | - | - | 0.16% | 0.24% | 0.99% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 831K | 0 | 379K | 0 | 0 | 0 | 0 | 0 | 24K | 0 | 0 |
| Cash from Financing | 149K | 456K | 171.93M | 357K | 1.92M | 17M | 0 | 12.45M | 0 | 9.19M | 0 | 134K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 149K | 456K | 171.93M | 357K | 1.92M | 16.9M | 0 | 12.39M | 0 | 9.14M | 0 | 134K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 96K | 0 | 59K | 0 | 49K | 0 | 0 |
| Net Change in Cash | -27.33M | 35.92M | -1.47M | 593K | -14.93M | 9.89M | 9.24M | 459K | -1.09M | -6.82M | 5.03M | -21.86M |
| Free Cash Flow | -22.12M | 14.21M | -15.18M | -16.76M | -23.44M | -407K | -15.24M | -17.12M | -18.38M | 73.58M | -13.98M | -13.68M |
| FCF Margin % | -269.28% | 33.47% | -140.65% | -174.09% | -248.85% | -5.53% | -222.7% | -200.59% | -317.68% | 1027.17% | - | - |
| FCF Growth % | 5.64% | 3592.14% | 0.45% | 2.09% | -27.54% | -100.55% | -9.01% | -25.15% | 21.56% | 482.13% | 29.81% | 23.53% |
| FCF per Share | -1.31 | 1.27 | -1.98 | -2.19 | -3.12 | -0.06 | -2.40 | -3.03 | -3.35 | 13.42 | -3.19 | -3.14 |
| FCF Conversion (FCF/Net Income) | 2.43x | 0.64x | 1.65x | 1.64x | 2.66x | 0.04x | 1.59x | 1.53x | 2.02x | -6.72x | 0.96x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |